Major Pharmaceuticals, Inc. Sustainability Profile
Major Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across various regions. Founded in the early 1980s, the company has established itself as a trusted provider of high-quality generic and over-the-counter medications. Specialising in a diverse range of therapeutic areas, Major Pharmaceuticals is known for its commitment to quality and affordability, offering products that cater to both healthcare professionals and consumers. The company’s unique approach to product development and stringent quality control measures have positioned it as a leader in the market. With a strong focus on innovation and customer satisfaction, Major Pharmaceuticals has achieved significant milestones, including numerous product launches and partnerships that enhance its market presence. The company continues to strive for excellence, ensuring that it meets the evolving needs of the healthcare sector.
DitchCarbon Score
How does Major Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Major Pharmaceuticals, Inc.'s score of 50 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Major Pharmaceuticals, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Cardinal Health, Inc., which means that any emissions data or climate commitments may be inherited from its parent organisation. As of now, Major Pharmaceuticals has not outlined any specific reduction targets or initiatives. However, it is important to note that the climate commitments and performance metrics of Cardinal Health, Inc. may influence Major Pharmaceuticals' sustainability strategies. Cardinal Health has engaged in various climate initiatives, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are aimed at reducing greenhouse gas emissions across its operations. While Major Pharmaceuticals, Inc. does not currently report its own emissions or reduction targets, it is positioned within a corporate family that is actively working towards climate commitments. The absence of specific data highlights the need for further transparency and accountability in the company's environmental impact efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2009 | 2010 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 148,856,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 212,644,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Major Pharmaceuticals, Inc.'s Industry?
How Carbon Intensive is Major Pharmaceuticals, Inc.'s Location?
Major Pharmaceuticals, Inc.'s Scope 3 Categories Breakdown
Major Pharmaceuticals, Inc.'s Scope 3 emissions, which increased by 5% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 93% of Scope 3 emissions.
Top Scope 3 Categories
Major Pharmaceuticals, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Major Pharmaceuticals, Inc. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.